Get an alert when CDC NORTH AFRICA HEALTHCARE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-04 (in 6mo)

Last made up 2025-10-21

Watchouts

None on the register

Cash

£3M

+191.1% vs 2023

Net assets

£53M

+3.5% vs 2023

Employees

0

Average over period

Profit before tax

£2M

+68.4% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover
Operating profit £11,585,299£21,758,566
Profit before tax £1,133,605£1,908,941
Net profit £1,015,941£1,779,982
Cash £931,638£2,711,634
Total assets less current liabilities £51,061,997£52,841,979
Net assets £51,061,997£52,841,979
Equity £51,061,997£52,841,979
Average employees 00
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Return on capital employed 22.7%41.2%
Gearing (liabilities / total assets) 0.2%0.2%
Current ratio 14.73x26.63x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“With support from British International Investment plc ("BII"), the Directors have a reasonable expectation that the Company will have adequate financial resources to continue in operational existence for at least the next 12 months. BII has issued a letter of support which confirms that BII will cover any ongoing expenses incurred by the Company and the Company has adequate cash and cash equivalents driven by investment income. Whilst the letter of support is not a legal contract, the Directors have full confidence that BII will continue to support the Company. In assessing the going concern status for the Company, the Directors have closely monitored the Company's investment portfolio throughout the year and has considered the cash flow forecasts of the intermediate parent company, BII. Current forecasts demonstrate that BII and its subsidiaries (the "Group") have sufficient liquid resources available to maintain planned investment pace for at least 12 months from the date of issue of the financial statements without needing to draw on the revolving credit facility. Having performed the assessment on going concern, the Directors consider it appropriate to prepare the financial statements of the Company on a going concern basis. The Directors consider the Company has adequate financial resources and liquidity and is well placed to manage business risks in the current economic environment to continue operations for a period of at least 12 months from the date of issue of the financial statements.”

Group structure

  1. CDC NORTH AFRICA HEALTHCARE LIMITED · parent
    1. Alfa Laboratories Egypt 19.7% · Egypt
    2. Alfa Scan 19.7% · Egypt
    3. El Safa for Medical Services 19.31% · Egypt

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 9 resigned

Name Role Appointed Born Nationality
PURKIS, Matthew James Secretary 2020-10-02
ROWLANDS, Simon Nicholas Director 2023-04-03 Jun 1957 British
Show 9 resigned officers
Name Role Appointed Resigned
EARL, Jane Secretary 2019-12-19 2020-10-02
PARVIEZ, Shazia Secretary 2019-10-22 2019-12-19
COLES, Christopher James Mckenzie Director 2019-10-22 2020-11-16
CORCORAN, Michael John Director 2019-10-29 2020-07-31
CUCCIOLI, Leandro German Director 2023-04-03 2024-05-22
EARL, Jane Director 2019-10-22 2023-04-04
MORGAN, Anthony David Director 2020-11-16 2024-01-23
OSBORNE, David Delano Franklin Director 2019-10-29 2020-11-16
SIMS, Carolyn Director 2020-10-02 2026-04-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
British International Investment Plc Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2019-10-22 Active

Filing timeline

Last 20 of 37 total filings

Date Type Category Description
2026-05-12 TM01 officers Termination director company with name termination date PDF
2025-10-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-08-06 AA accounts Accounts with accounts type full
2024-11-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-24 AA accounts Accounts with accounts type full
2024-05-24 TM01 officers Termination director company with name termination date PDF
2024-01-25 TM01 officers Termination director company with name termination date PDF
2023-10-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-06 AA accounts Accounts with accounts type small
2023-04-20 AP01 officers Appoint person director company with name date PDF
2023-04-14 AP01 officers Appoint person director company with name date PDF
2023-04-14 TM01 officers Termination director company with name termination date PDF
2022-10-26 CS01 confirmation-statement Confirmation statement with updates PDF
2022-07-13 AA accounts Accounts with accounts type full
2022-05-04 PSC05 persons-with-significant-control Change to a person with significant control PDF
2021-10-29 CS01 confirmation-statement Confirmation statement with updates PDF
2021-07-22 AA accounts Accounts with accounts type full
2021-03-25 SH01 capital Capital allotment shares PDF
2021-03-24 SH01 capital Capital allotment shares PDF
2021-01-11 SH14 capital Capital redomination of shares

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page